Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Operating Expenses Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual operating expenses in 2023 was 5.95 Million USD , up 4.87% from previous year.
Medtecs International Corporation Limited's latest quarterly operating expenses in 2024 Q2 was 9.3 Million USD , down -52.77% from previous quarter.
Medtecs International Corporation Limited reported a annual operating expenses of 29.1 Million USD in annual operating expenses 2022, up 14.92% from previous year.
Medtecs International Corporation Limited reported a annual operating expenses of 25.32 Million USD in annual operating expenses 2021, down -28.01% from previous year.
Medtecs International Corporation Limited reported a quarterly operating expenses of 30.51 Million USD for 2023 FY, up 4.87% from previous quarter.
Medtecs International Corporation Limited reported a quarterly operating expenses of 10.3 Million USD for 2023 Q2, down -29.64% from previous quarter.

Annual Operating Expenses Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Operating Expenses of Medtecs International Corporation Limited (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	5.95 Million USD	4.87%
2022	29.1 Million USD	14.92%
2021	25.32 Million USD	-28.01%
2020	35.17 Million USD	369.28%
2019	7.49 Million USD	-2.14%
2018	7.66 Million USD	6.23%
2017	7.21 Million USD	10.21%
2016	6.54 Million USD	-3.01%
2015	6.74 Million USD	10.57%
2014	6.1 Million USD	-10.71%
2013	6.83 Million USD	-5.26%
2012	7.21 Million USD	-5.44%
2011	7.62 Million USD	-14.32%
2010	8.9 Million USD	-7.91%
2009	9.66 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	9.3 Million USD	-52.77%
2023 FY	30.51 Million USD	4.87%
2023 Q2	10.3 Million USD	-29.64%
2023 Q4	19.71 Million USD	91.36%
2022 Q2	12.76 Million USD	-9.63%
2022 FY	29.1 Million USD	14.92%
2022 Q4	14.63 Million USD	14.69%
2021 Q4	14.12 Million USD	21.59%
2021 Q2	11.61 Million USD	-57.82%
2021 FY	25.32 Million USD	-28.01%
2020 Q2	7.58 Million USD	145.45%
2020 Q4	27.53 Million USD	262.96%
2020 FY	35.17 Million USD	369.28%
2019 Q4	3.09 Million USD	-19.61%
2019 Q2	3.84 Million USD	4.63%
2019 FY	7.49 Million USD	-2.14%
2018 Q4	3.67 Million USD	-1.66%
2018 FY	7.66 Million USD	6.23%
2018 Q2	3.73 Million USD	7.69%
2017 Q4	3.46 Million USD	-9.23%
2017 Q2	3.82 Million USD	36.68%
2017 FY	7.21 Million USD	10.21%
2016 FY	6.54 Million USD	-3.01%
2016 Q4	2.79 Million USD	-19.23%
2016 Q2	3.46 Million USD	-0.4%
2015 FY	6.74 Million USD	10.57%
2015 Q4	3.47 Million USD	9.2%
2015 Q2	3.18 Million USD	28.39%
2014 Q2	3.25 Million USD	-5.6%
2014 FY	6.1 Million USD	-10.71%
2014 Q4	2.48 Million USD	-23.72%
2013 Q4	3.44 Million USD	-4.04%
2013 FY	6.83 Million USD	-5.26%
2013 Q2	3.58 Million USD	0.0%
2012 Q4	- USD	0.0%
2012 FY	7.21 Million USD	-5.44%
2011 Q2	- USD	0.0%
2011 FY	7.62 Million USD	-14.32%
2011 Q4	- USD	0.0%
2010 FY	8.9 Million USD	-7.91%
2010 Q4	- USD	0.0%
2009 Q4	- USD	0.0%
2009 FY	9.66 Million USD	0.0%

Peer Operating Expenses Comparison of Medtecs International Corporation Limited

Name	Operating Expenses	Operating Expenses Difference
Nang Kuang Pharmaceutical Co., Ltd.	495.65 Million TWD	98.798%
Maxigen Biotech Inc.	274.24 Million TWD	97.828%
SciVision Biotech Inc.	312.85 Million TWD	98.096%
Bionime Corporation	673.63 Million TWD	99.116%
Pegavision Corporation	1.68 Billion TWD	99.647%
Visco Vision Inc.	522.44 Million TWD	98.86%